日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Feasibility of long-range telesurgical robotic radical gastrectomy in a live porcine model

在活体猪模型中进行远程机器人辅助根治性胃切除术的可行性研究

Chia, Daryl Kai Ann; Suda, Koichi; Ho, Wei-En; Lee, Bu Sung; Suzuki, Kazumitsu; Shibasaki, Susumu; Harada, Tatsuhiko; Murai, Jun; Oe, Masafumi; Asai, Hirochika; Tomine, Takashi; Sato, Hirotaka; Yoro, Masahiro; Ohashi, Masanao; Kitatsuji, Hiroaki; Green, Simon Peter; Xiong, Ying; Shabbir, Asim; Lomanto, Davide; So, Jimmy Bok Yan; Kim, Guowei; Uyama, Ichiro

Association of circulating histone H3 and high mobility group box 1 levels with postoperative prognostic indicators in intensive care unit patients: a single-center observational study

循环组蛋白H3和高迁移率族蛋白1水平与重症监护病房患者术后预后指标的相关性:一项单中心观察性研究

Sawada, Ken; Shimomura, Yasuyo; Hasegawa, Daisuke; Harada, Tatsuhiko; Nakamura, Tomoyuki; Kuriyama, Naohide; Hara, Yoshitaka; Komura, Hidefumi; Nishida, Osamu

Establishment of a new practical telesurgical platform using the hinotori™ Surgical Robot System: a preclinical study

利用hinotori™手术机器人系统建立新型实用远程手术平台:一项临床前研究

Nakauchi, Masaya; Suda, Koichi; Nakamura, Kenichi; Tanaka, Tsuyoshi; Shibasaki, Susumu; Inaba, Kazuki; Harada, Tatsuhiko; Ohashi, Masanao; Ohigashi, Masayuki; Kitatsuji, Hiroaki; Akimoto, Shingo; Kikuchi, Kenji; Uyama, Ichiro

Vildagliptin-induced ground-glass nodules mimicking lung metastases in a cancer patient receiving Lactobacillus probiotic supplementation

服用乳酸杆菌益生菌补充剂的癌症患者出现维格列汀诱发的磨玻璃结节,类似肺转移瘤

Tanaka, Yasuhiro; Soda, Hiroshi; Fukuda, Yuichi; Nio, Kenta; Ono, Sawana; Tomono, Hiromi; Shimada, Midori; Yoshida, Masataka; Harada, Tatsuhiko; Umemura, Asuka; Iwasaki, Keisuke; Yamaguchi, Hiroyuki; Mukae, Hiroshi

Dynamics of blood neutrophil-related indices during nivolumab treatment may be associated with response to salvage chemotherapy for non-small cell lung cancer: A hypothesis-generating study

纳武利尤单抗治疗期间血液中性粒细胞相关指标的动态变化可能与非小细胞肺癌挽救性化疗的疗效相关:一项假设生成性研究

Soda, Hiroshi; Ogawara, Daiki; Fukuda, Yuichi; Tomono, Hiromi; Okuno, Daisuke; Koga, Seiko; Taniguchi, Hirokazu; Yoshida, Masataka; Harada, Tatsuhiko; Umemura, Asuka; Yamaguchi, Hiroyuki; Mukae, Hiroshi

Pitfalls in diagnosis with the use of circulating tumor-derived epidermal growth factor receptor mutations in lung cancer harboring pretreatment T790M

在诊断携带治疗前T790M突变的肺癌时,循环肿瘤衍生表皮生长因子受体突变的陷阱

Ogawara, Daiki; Soda, Hiroshi; Suyama, Takayuki; Yoshida, Masataka; Harada, Tatsuhiko; Fukuda, Yuichi; Mukae, Hiroshi

Pulmonary pleomorphic carcinoma with few PD-1-positive immune cells and regulatory T cells that showed a complete response to nivolumab

肺多形性癌,PD-1阳性免疫细胞和调节性T细胞较少,对纳武利尤单抗治疗有完全反应

Okamura, Kazuaki; Fukuda, Yuichi; Soda, Hiroshi; Ogawara, Daiki; Iwasaki, Keisuke; Fuchi, Shinichiro; Suyama, Takayuki; Yoshida, Masataka; Harada, Tatsuhiko; Fukuda, Minoru; Mukae, Hiroshi

Successful treatment with nivolumab for lung cancer with low expression of PD-L1 and prominent tumor-infiltrating B cells and immunoglobulin G

使用纳武利尤单抗成功治疗PD-L1低表达且肿瘤浸润B细胞和免疫球蛋白G显著的肺癌

Suyama, Takayuki; Fukuda, Yuichi; Soda, Hiroshi; Ogawara, Daiki; Iwasaki, Keisuke; Hara, Takuya; Yoshida, Masataka; Harada, Tatsuhiko; Umemura, Asuka; Yamaguchi, Hiroyuki; Mukae, Hiroshi

Presence of few PD-1-expressing tumor-infiltrating immune cells is a potential predictor of improved response to salvage chemotherapy following nivolumab for non-small cell lung cancer: An exploratory case series

肿瘤浸润免疫细胞中PD-1表达较少可能是非小细胞肺癌患者接受纳武利尤单抗治疗后,挽救性化疗疗效改善的潜在预测因子:一项探索性病例系列研究

Ogawara, Daiki; Soda, Hiroshi; Tomono, Hiromi; Iwasaki, Keisuke; Hara, Takuya; Jinnai, Saeko; Funayama, Takatomo; Okuno, Daisuke; Taniguchi, Hirokazu; Yoshida, Masataka; Harada, Tatsuhiko; Umemura, Asuka; Fukuda, Yuichi; Yamaguchi, Hiroyuki; Mukae, Hiroshi

Nivolumab infusion reaction manifesting as plantar erythema and pulmonary infiltrate in a lung cancer patient

肺癌患者接受纳武利尤单抗输注后出现足底红斑和肺部浸润反应

Ogawara, Daiki; Soda, Hiroshi; Ikehara, Susumu; Sumiyoshi, Makoto; Iwasaki, Keisuke; Okuno, Daisuke; Dohtsu, Yosuke; Taniguchi, Hirokazu; Harada, Tatsuhiko; Fukuda, Yuichi; Mukae, Hiroshi